相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors
Ann G. Coumbe et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study
Jesper Lindhardsen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Effects of Biologic Agents and Other Disease-Modifying Antirheumatic Drugs on Cardiovascular Outcomes in Psoriasis and Psoriatic Arthritis: A Systematic Review
April W. Armstrong et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies
Jeremy Hugh et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Glucocorticoid Dose Thresholds Associated With All-Cause and Cardiovascular Mortality in Rheumatoid Arthritis
Inmaculada del Rincon et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs
Daniel H. Solomon et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist
Daniel H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis
Anne M. Kerola et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
THE RISK OF ACUTE CORONARY SYNDROMES IN RA IN RELATION TO TNF INHIBITORS AND RISKS IN THE GENERAL POPULATION: A NATIONAL COHORT STUDY
L. Ljung et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
THE EFFECT OF ADALIMUMAB ON RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: A META-ANALYSIS OF RANDOMIZED TRIALS
G. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Propensity-Adjusted Association of Methotrexate With Overall Survival in Rheumatoid Arthritis
Mary Chester M. Wasko et al.
ARTHRITIS AND RHEUMATISM (2013)
Emerging Anti-inflammatory Therapies for Atherosclerosis
François Roubille et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study
O. Ahlehoff et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Psoriasis Is Not Associated with Atherosclerosis and Incident Cardiovascular Events: The Rotterdam Study
Emmilia A. Dowlatshahi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
N. Bhala et al.
LANCET (2013)
Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study
J. Antonio Avina-Zubieta et al.
RHEUMATOLOGY (2013)
Important issues at heart: cardiovascular risk management in rheumatoid arthritis
Camille Roubille et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2013)
Methotrexate Reduces the Occurrence of Cerebrovascular Events among Taiwanese Psoriatic Patients: A Nationwide Population-based Study
Cheng-Che E. Lan et al.
ACTA DERMATO-VENEREOLOGICA (2012)
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
Juan Antonio Avina-Zubieta et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Association Between Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis
Jashin J. Wu et al.
ARCHIVES OF DERMATOLOGY (2012)
Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: A nationwide cohort study
Yi-Ju Chen et al.
ARTHRITIS AND RHEUMATISM (2012)
Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis
Kaisa M. Maeki-Petaejae et al.
CIRCULATION (2012)
Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
Renata Micha et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Comparative Effectiveness of Pain Management Interventions for Hip Fracture: A Systematic Review
Ahmed M. Abou-Setta et al.
ANNALS OF INTERNAL MEDICINE (2011)
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
Jeffrey D. Greenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study
J. Antonio Avina-Zubieta et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study
K. Abuabara et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Sarah L. Westlake et al.
RHEUMATOLOGY (2011)
Tumor necrosis factor-alpha blockade, cardiovascular outcomes, and survival in rheumatoid arthritis
Ziyad Al-Aly et al.
TRANSLATIONAL RESEARCH (2011)
Systematic Review and Meta-Analysis: Anti-Tumor Necrosis Factor α Therapy and Cardiovascular Events in Rheumatoid Arthritis
Cheryl Barnabe et al.
ARTHRITIS CARE & RESEARCH (2011)
Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study
Lena Innala et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Sven Trelle et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Relation of Baseline High-Sensitivity C-Reactive Protein Level to Cardiovascular Outcomes With Rosuvastatin in the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)
Paul M. Ridker et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
M. J. L. Peters et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
No Evidence of Association Between Anti-Tumor Necrosis Factor Treatment and Mortality in Patients With Rheumatoid Arthritis Results From the British Society for Rheumatology Biologics Register
Mark Lunt et al.
ARTHRITIS AND RHEUMATISM (2010)
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Sarah L. Westlake et al.
RHEUMATOLOGY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Tumor necrosis factor-α antagonist use and heart failure in elderly patients with rheumatoid arthritis
Soko Setoguchi et al.
AMERICAN HEART JOURNAL (2008)
The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis - A cohort and nested case-control analysis
Frederick Wolfe et al.
ARTHRITIS AND RHEUMATISM (2008)
Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: A nested, case-control study
Zurab Nadareishvili et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Does tumor necrosis factor a inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
Joachim Listing et al.
ARTHRITIS AND RHEUMATISM (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis
V. F. Panoulas et al.
RHEUMATOLOGY (2008)
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor α therapy -: Results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2007)
All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists
Loreto Carmona et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Glucocorticoids and cardiovascular events in rheumatoid arthritis - A population-based cohort study
John M. Davis et al.
ARTHRITIS AND RHEUMATISM (2007)
Antirheumatic drug use and the risk of acute myocardial infarction
Samy Suissa et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study
Vokko P. van Halm et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis - A ten-year followup study of a primary care-based inception cohort
NJ Goodson et al.
ARTHRITIS AND RHEUMATISM (2005)
Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis
S Bernatsky et al.
RHEUMATOLOGY (2005)
Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis
S Prodanowich et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
The risk of congestive heart failure in rheumatoid arthritis - A population-based study over 46 years
PJ Nicola et al.
ARTHRITIS AND RHEUMATISM (2005)
Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL)
DL Mann et al.
CIRCULATION (2004)
Heart failure in rheumatoid arthritis: Rates, predictors, and the effect of anti-tumor necrosis factor therapy
F Wolfe et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease
L Wei et al.
ANNALS OF INTERNAL MEDICINE (2004)
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
ES Chung et al.
CIRCULATION (2003)
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis
DH Solomon et al.
CIRCULATION (2003)
Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis
DJ Watson et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study
HK Choi et al.
LANCET (2002)
Anti-tumor necrosis factor-α antibody limits heart failure in a transgenic model
T Kadokami et al.
CIRCULATION (2001)
分享论文
